Medical News

RSS

GSD receives FDA clearance for next-generation Lyme disease Line Immunoassay

Gold Standard Diagnostics (GSD) today announced FDA clearance of its next-generation Lyme disease Line Immunoassay which offers excellent specificity and sensitivity at any disease stage.

28 Jun 2012

Viewpoints: Look who's worried about activist judges now; No matter what the court decides, a bipartisan plan will be needed

It's a great pleasure, in this week when the entire political world is hanging on the Supreme Court's health care ruling, to welcome so many liberals to a cause dear to my heart: The crusade for judicial restraint.

28 Jun 2012

‘Risky’ view of thrombolysis in subtherapeutic warfarin patients disputed

A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.

27 Jun 2012

Two coffees a day keep heart failure risk at bay

Drinking two cups of coffee a day may significantly reduce risk for heart failure, while anymore than that could significantly increase the risk, researchers say.

27 Jun 2012

FDA approves test for dengue virus infection

The first test that can detect the presence of the dengue virus itself rather than antibodies to the virus has been approved for use by the US Food and Drug Administration.

27 Jun 2012

Taking steps to reduce diabetes risk

Modest amounts of daily walking can significantly reduce the risk for incident diabetes in obese and relatively inactive individuals, show findings from a US study.

27 Jun 2012

$Chinese herbal preparation reduces fragility fractures$

Chinese herbal preparation reduces fragility fractures

Herbal Fufang – a multi-herbal preparation used in traditional Chinese medicine –increases bone mineral density and reduces fragility fractures in postmenopausal women, Chinese researchers report.

27 Jun 2012

Flat polyps may explain colorectal cancer screening discrepancy

Poor ability to detect sessile serrated polyps may explain why endoscopy is more effective at reducing cancer in the distal than the proximal colon, US researchers have discovered.

27 Jun 2012

Exposure to phthalates may raise childhood obesity risk

Obese children have higher exposure to phthalates than nonobese children, suggest results presented at ENDO 2012 in Houston, Texas, USA, the annual meeting of The Endocrine Society.

27 Jun 2012

Psychiatric inpatients have low vitamin D levels

Results from a New Zealand study show that vitamin D deficiency is common in psychiatric inpatients, particularly among patients with schizophrenia and those of Maori descent.

27 Jun 2012

Review confirms impaired cognition in prodromal psychosis

Patients at high risk for psychosis show significant and widespread impairments in neurocognitive functioning and social cognition, results from a systematic review and meta-analysis of published studies show.

27 Jun 2012

Common cold remedy ‘not recommended’ for children

Research suggests that using steam inhalation as a remedy for a blocked nose or sinuses in children can be dangerous due to a high scalding risk associated with this therapy.

27 Jun 2012

‘Risky’ view of thrombolysis in subtherapeutic warfarin patients disputed

A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.

27 Jun 2012

Protein kinase A activated in the nucleus as well as the cytoplasm

Using a new tool allowing proteins in a living cell to be manipulated in real time, researchers at Johns Hopkins have stumbled across the answer to a longstanding debate about where and how a certain protein is turned on in the cell. Reporting in the February 2012 issue of Nature Chemical Biology, scientists show that protein kinase A is also activated in the nucleus rather than inside the cell’s body, a challenge to traditional beliefs.

27 Jun 2012

Second potential immune checkpoint target for cancer immunotherapy announced by Compugen

Compugen Ltd. (NASDAQ: CGEN) announced today results demonstrating the therapeutic potential of CGEN-15022, a Compugen-discovered B7/CD28-like membrane protein, as an immune checkpoint target for treatment of multiple cancers.

27 Jun 2012

Federal government makes $13 billion in duplicative payments to veterans

A new study published today in the Journal of the American Medical Association (JAMA) found that the federal government made about $13 billion in duplicative payments to provide health-care services to veterans who were simultaneously enrolled in Medicare Advantage plans from 2004-2009.

27 Jun 2012

EU agenda focusses on lifesyle changes towards healthy diets and improved physical activity

A common Strategic Research Agenda of 22 countries in Europe focusses on lifesyle changes towards healthy diets and improved physical activity. Biomarker research, nutrigenomics, perzonalized food supplies and the prevention of chronic lifestyle related diseases are key-fields of the Joint Programming Inititative " A Healthy Diet for a Healthy Life."

27 Jun 2012

Registry proves invaluable for fibromuscular dysplasia patients

A patient registry is proving invaluable in cataloging the clinical features, symptoms, severity, and outcomes of fibromuscular dysplasia (FMD), a non-inflammatory vascular disease that can cause narrowing of arteries in the carotid (neck) and renal (kidney) arteries, which can result in headache, strokes, and aneurysms.

27 Jun 2012

Indoor tanning beds banned for minors

Rhode Island took a great step today to protect youth from the dangers of skin cancer by prohibiting the use of indoor tanning beds by minors under the age of 18 without parental consent. This important action is based on significant scientific evidence that indoor tanning is undeniably linked to increased risk of developing melanoma and other forms of skin cancer.

27 Jun 2012

Combination of radiation therapies effectively treat prostate cancer, lower chances of recurrence

A recent Phase I/II clinical trial has shown that a new combination of radiation therapies developed at Virginia Commonwealth University Massey Cancer Center escalates radiation doses to safely and effectively treat prostate cancer and lower the risk of recurrence with minimal radiation exposure to nearby healthy tissue and organs.

27 Jun 2012